Desano Pharmaceuticals Private Limited, a active foreign private limited company, was established on 19 November 2012 in Bengaluru, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233KA2012FTC130244. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹55.00 Cr and a paid-up capital of ₹49.69 Cr.
It upholds a compliant status. Employing 163 professional, Its leadership includes Li Jingpeng (Director), Sasikumar Kannaiyan (Director). Past directors included Li Jinliang, Manorama Avinash, Nikita Laxmana Shettigar. It holds ₹50.00 Cr open charges and no settled loans. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at No. 77D, Kiadb Industrial Area Jigani,, Bengaluru, Karnataka, 560105.
U24233KA2012FTC130244
130244
19 November 2012
₹55.00 Cr
₹49.69 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Desano Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Li Jingpeng | Director | 19 Nov 2012 | Current |
| Sasikumar Kannaiyan | Director | 15 Nov 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Jan 2020 | Past |
| Pramod Abcsdd | Director | 26 Jul 2017 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 20 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Aug 2019 | Past |
| Pramod Abcsdd | Director | 22 Jul 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Desano Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 59.9% increase in profit. The company's net worth dipped by a decrease of 1.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Desano Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹500,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Apr 2024 | Others | ₹50.00 Cr | Open |
Explore comprehensive loan charge details -
Desano Pharmaceuticals has a workforce of 163 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Desano Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Desano Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Desano Pharmaceuticals Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Desano Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was completed.
A charge with Others of Rs. 50.00 Cr registered on 16 Apr 2024 with Charge ID 100916383 was modified on 13 May 2024. was recorded as a recent event.
A charge with Others amounted to Rs. 50.00 Cr with Charge ID 100916383 was registered on 16 Apr 2024. was recorded as a recent event.
Shreya Aruna Kamath was appointed as a Company Secretary was appointed as a Company Secretary on 15 Jun 2023 & has been associated with this company since 2 years 5 months . was recorded as a recent event.
Sasikumar Kannaiyan was appointed as a Director was appointed as a Director on 15 Nov 2019 & has been associated with this company since 6 years 16 days . was recorded as a recent event.
The CIN of Desano Pharmaceuticals Private Limited is U24233KA2012FTC130244.
Desano Pharmaceuticals Private Limited is headquartered at No. 77D, Kiadb Industrial Area Jigani,, Bengaluru, Karnataka, 560105.
Desano Pharmaceuticals Private Limited was incorporated on 19 November 2012.
The current directors of Desano Pharmaceuticals Private Limited are
The primary industry of Desano Pharmaceuticals Private Limited is Manufacturing.
Desano Pharmaceuticals Private Limited is unlisted.
The authorized capital of Desano Pharmaceuticals Private Limited is ₹55.00 Cr, and the paid-up capital is ₹49.69 Cr.
The compliance status of Desano Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX